Biolexis Therapeutics

Biolexis Therapeutics specializes in AI-enabled drug discovery. Their proprietary MolecuLern™ platform accelerates the identification and development of novel therapeutic candidates for a wide range of diseases including cancer, autoimmune and inflammatory disorders, neurodegenerative diseases, and metabolic diseases. Biolexis Therapeutics has 5 oral small molecule candidates in their pipeline.

Jobs: